Department of Surgery, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan.
J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):47-54. doi: 10.1007/s00534-012-0563-1.
We propose a management strategy for acute cholangitis and cholecystitis according to the severity assessment. For Grade I (mild) acute cholangitis, initial medical treatment including the use of antimicrobial agents may be sufficient for most cases. For non-responders to initial medical treatment, biliary drainage should be considered. For Grade II (moderate) acute cholangitis, early biliary drainage should be performed along with the administration of antibiotics. For Grade III (severe) acute cholangitis, appropriate organ support is required. After hemodynamic stabilization has been achieved, urgent endoscopic or percutaneous transhepatic biliary drainage should be performed. In patients with Grade II (moderate) and Grade III (severe) acute cholangitis, treatment for the underlying etiology including endoscopic, percutaneous, or surgical treatment should be performed after the patient's general condition has been improved. In patients with Grade I (mild) acute cholangitis, treatment for etiology such as endoscopic sphincterotomy for choledocholithiasis might be performed simultaneously, if possible, with biliary drainage. Early laparoscopic cholecystectomy is the first-line treatment in patients with Grade I (mild) acute cholecystitis while in patients with Grade II (moderate) acute cholecystitis, delayed/elective laparoscopic cholecystectomy after initial medical treatment with antimicrobial agent is the first-line treatment. In non-responders to initial medical treatment, gallbladder drainage should be considered. In patients with Grade III (severe) acute cholecystitis, appropriate organ support in addition to initial medical treatment is necessary. Urgent or early gallbladder drainage is recommended. Elective cholecystectomy can be performed after the improvement of the acute inflammatory process. Free full-text articles and a mobile application of TG13 are available via http://www.jshbps.jp/en/guideline/tg13.html.
我们根据严重程度评估提出了急性胆囊炎和胆管炎的管理策略。对于Ⅰ级(轻度)急性胆囊炎,初始的内科治疗包括使用抗菌药物可能对大多数病例足够。对于初始内科治疗无反应者,应考虑胆道引流。对于Ⅱ级(中度)急性胆囊炎,应早期进行胆道引流并给予抗生素。对于Ⅲ级(重度)急性胆囊炎,需要适当的器官支持。在血流动力学稳定后,应进行紧急内镜或经皮经肝胆道引流。对于Ⅱ级(中度)和Ⅲ级(重度)急性胆囊炎患者,在患者一般情况改善后,应针对潜在病因进行治疗,包括内镜、经皮或手术治疗。对于Ⅰ级(轻度)急性胆囊炎患者,如果可能,同时进行病因治疗,如内镜下括约肌切开术治疗胆总管结石,并进行胆道引流。Ⅰ级(轻度)急性胆囊炎的一线治疗是早期腹腔镜胆囊切除术,而对于Ⅱ级(中度)急性胆囊炎,在初始内科治疗(联合抗菌药物)后延迟/择期行腹腔镜胆囊切除术是一线治疗。对于初始内科治疗无反应者,应考虑胆囊引流。对于Ⅲ级(重度)急性胆囊炎,除初始内科治疗外,还需要适当的器官支持。建议进行紧急或早期胆囊引流。在急性炎症过程改善后,可以进行择期胆囊切除术。可通过 http://www.jshbps.jp/en/guideline/tg13.html 获取全文文章和 TG13 移动应用程序。